Consolidated Statements of Stockholders’ Equity - USD ($)	Total	Common Stock	Additional Paid-in Capital	Stock Subscriptions	Treasury Stock, At Cost	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019		178,931,312
Beginning balance at Dec. 31, 2019	$ 27,314,316	$ 1,789	$ 47,154,147	$ 0	$ 0	$ 0	$ (19,841,620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity based compensation	$ 6,528,356		6,528,356
Stock option exercises (in shares)	1,736,476	1,492,060
Stock option exercises	$ 427,731	$ 14	427,717
Restricted stock issuances and vesting of awards (in shares)		464,736
Restricted stock issuances and vesting of awards	482,488	$ 5	482,483
Stock subscriptions receivable related to stock option exercises (in shares)		244,416
Stock subscriptions receivable related to stock option exercises	0	$ 3	77,912	(77,915)
Stock subscriptions collected related to stock option exercises	8,475			8,475
Repurchase of common stock (in shares)		(152,035)
Repurchase of common stock	(875,232)				(875,232)
Retirement of common stock (in shares)		(343,750)
Retirement of common stock	(2,234)	$ (3)	(2,231)
Proceeds from issuance of common stock, net of issuance costs (in shares)		16,289,935
Proceeds from issuance of common stock, net of issuance costs	57,972,752	$ 162	57,972,590
Foreign currency translation adjustment	494,505					494,505
Net loss	(32,392,740)						(32,392,740)
Ending balance (in shares) at Dec. 31, 2020		196,926,674
Ending balance at Dec. 31, 2020	59,958,417	$ 1,970	112,640,974	(69,440)	(875,232)	494,505	(52,234,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity based compensation	$ 9,013,029		9,013,029
Stock option exercises (in shares)	1,683,397	1,486,341
Stock option exercises	$ 765,786	$ 15	765,771
Restricted stock issuances and vesting of awards (in shares)		1,569,681
Restricted stock issuances and vesting of awards	5,148,725	$ 16	5,148,709
Issuance of restricted stock units for settlement of accrued expenses	1,996,779		1,996,779
Conversion of liability-classified incentive awards to stockholder's equity	8,580,123		8,580,123
Stock subscriptions receivable related to stock option exercises (in shares)		197,056
Stock subscriptions receivable related to stock option exercises	0	$ 2	196,102	(196,104)
Stock subscriptions collected related to stock option exercises	246,999			246,999
Repurchase of common stock (in shares)		(508,083)
Repurchase of common stock	(2,816,095)	$ (5)			(2,816,090)
Proceeds from issuance of common stock, net of issuance costs (in shares)		4,559,270
Proceeds from issuance of common stock, net of issuance costs	29,997,232	$ 46	29,997,186
Foreign currency translation adjustment	69,406					69,406
Net loss	(75,168,363)						(75,168,363)
Ending balance (in shares) at Dec. 31, 2021		204,230,939
Ending balance at Dec. 31, 2021	$ 37,792,038	$ 2,044	$ 168,338,673	$ (18,545)	$ (3,691,322)	$ 563,911	$ (127,402,723)